MATERNAL GRAVES DISEASE AND ABNORMAL CYP2D6 GENOTYPE WITH FETAL HYPERTHYROIDISM

AACE Clinical Case Reports
Christopher Spoke, Christopher Martin

Abstract

Fetal hyperthyroidism is a rare yet potentially fatal complication of past or present maternal Graves disease (GD). Our objective was to present a unique case of fetal hyperthyroidism in a mother with a prior history of GD and a cytochrome P450 2D6 (CYP2D6) polymorphism. The clinical course in addition to serial laboratory and imaging results are presented. These include thyroid-stimulating hormone, free thyroxine, and thyrotropin receptor antibody levels, as well as fetal ultrasound, doppler fetal heart rate, and cordocentesis testing. A 27-year-old with a history of GD previously treated with radioiodine and a known cytochrome P450 polymorphism was referred to an endocrinology clinic at 17 weeks gestation for evaluation and management of fetal thyrotoxicosis. Despite close follow-up with a multidisciplinary care team and an aggressive "block and replace" treatment approach, progressive disease resulted in intrauterine fetal demise at 28 weeks gestation. To our knowledge, this is the first published case report of fetal hyperthyroidism accompanied by a maternal CYP2D6 polymorphism. We hypothesize that the maternal CYP2D6 poor metabolizer phenotype prevents formation of antithyroid drug (ATD) metabolites and thus decreases the ...Continue Reading

References

Nov 1, 1983·The Journal of Clinical Endocrinology and Metabolism·M Zakarija, J M McKenzie
Jun 1, 1982·Klinische Wochenschrift·G Benker, D Reinwein
Mar 1, 1997·Clinical Obstetrics and Gynecology·D A Fisher
Dec 16, 1998·Journal of Child and Adolescent Psychopharmacology·J R Oesterheld
Sep 13, 2003·The Journal of Clinical Endocrinology and Metabolism·Pratima K SinghAnn M Gronowski
Aug 5, 2004·The Journal of Clinical Endocrinology and Metabolism·Robert HumeUNKNOWN Scottish Preterm Thyroid Group
Nov 24, 2007·Fetal Diagnosis and Therapy·Kasemsri SrisupunditTheera Tongsong
Nov 5, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Guy Van VlietE Martin Ritzén
Mar 19, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Fang XieXinxin Ding
Aug 28, 2013·American Journal of Obstetrics and Gynecology·UNKNOWN Society for Maternal-Fetal Medicine (SMFM)Vincenzo Berghella
Nov 20, 2013·Indian Journal of Endocrinology and Metabolism·Chandar Mohan Batra
Oct 17, 2014·Clinical and Molecular Hepatology·Reza HeidariNarges Abdoli
Nov 26, 2014·Journal of Perinatology : Official Journal of the California Perinatal Association·Y SatoN Mitsuda
Feb 25, 2015·Obstetrics and Gynecology·Meghan A DonnellyLynn A Barbour
Oct 5, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xian PanHyunyoung Jeong
Jan 7, 2017·Thyroid : Official Journal of the American Thyroid Association·Erik K AlexanderScott Sullivan
Apr 26, 2017·Türk Pediatri Arşivi·Selim Kurtoğlu, Ahmet Özdemir
Jul 18, 2017·Frontiers in Endocrinology·Ines BucciGiorgio Napolitano
Oct 9, 2018·Case Reports in Women's Health·Paraskevi KazakouEleni Anastasiou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.